MPX APPOINTS NEW CHIEF FINANCIAL OFFICER

TORONTO, ONTARIO, January 16, 2018 – MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial Officer, effective January 15, 2018, subject to regulatory approval. Mr. McLaren br...
Read More